Membranous Nephropathy: Clinical Trials

4 trials for Membranous Nephropathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting. 4 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Completed 2, Recruiting 2
Phase 22Completed 1, Recruiting 1

Follow Membranous Nephropathy: new trials by email Literature Review of Membranous Nephropathy trials Research Report on Membranous Nephropathy

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combination of Rituximab and Cyclosporine in the Treatment of Primary Membranous Nephropathy
Rituximab combined with cyclosporine, rituximab - Membranous Nephropathy
Phase 2 / Phase 3RecruitingPeking University First Hospital902026-01-212026-10-06
Personalized Rituximab Treatment Based on Artificial Intelligence in Membranous Nephropathy (iRITUX)
RiTUXimab Injection - Membranous Nephropathy
Phase 3RecruitingCentre Hospitalier Universitaire de Nice1202025-02-042026-06-22
Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy
TACROLIMUS, RITUXIMAB, METHYLPREDNISOLONE - MEMBRANOUS NEPHROPATHY
Phase 3CompletedHospital Universitario 12 de Octubre862014-01-012020-01-18
Rituximab in Membranous Nephropathy
Rituximab - Membranous Nephropathy
Phase 2 / Phase 3CompletedMayo Clinic152004-08-012011-02-25

Narrower conditions

Glomerulonephritis, Membranous (4)

Broader conditions

Autoimmune Diseases (4)  ·  Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Glomerulonephritis (4)  ·  Immune System Diseases (4)  ·  Kidney Diseases (4)  ·  Male Urogenital Diseases (4)  ·  Nephritis (4)  ·  Urogenital Diseases (4)  ·  Urologic Diseases (4)

Interventions

Rituximab (4)  ·  Cyclophosphamide (1)  ·  Cyclosporine (1)  ·  Methylprednisolone (1)  ·  Tacrolimus (1)

Sponsors

Centre Hospitalier Universitaire de Nice (1)  ·  Hospital Universitario 12 de Octubre (1)  ·  Mayo Clinic (1)  ·  Peking University First Hospital (1)

Countries

China (1)  ·  France (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Fernando C. Fervenza, M.D., Ph.D. (1)

Results publications

PMID 34778952, PMID 40180405